HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Plasma lipoproteins and incidence of non-insulin-dependent diabetes mellitus in Pima Indians: protective effect of HDL cholesterol in women.

Abstract
The role of plasma lipoproteins in the development of non-insulin-dependent diabetes mellitus (NIDDM) was studied in 787 non-diabetic (2-h glucose < 11.1 mmol/l) Pima Indians (265 men and 522 women). Subjects were followed for a mean of 9.8 (range: 1.8-16.4) years, during which 261 (76 men and 185 women) developed NIDDM. In men and women, very-low-density lipoprotein (VLDL) cholesterol, VLDL triglyceride, low-density lipoprotein triglyceride and total triglyceride, controlled for age, predicted NIDDM (P < 0.01 for each). These effects diminished when controlled for age, sex, body mass index, systolic blood pressure and 2-h glucose. However, high-density lipoprotein (HDL) cholesterol, controlled for age, body mass index, systolic blood pressure and 2-h glucose, was a significant protective factor for NIDDM in women (hazard rate ratio (HRR) = 0.35, 95% CI (0.23-0.54), P < 0.001, 90th compared with 10th percentile) but not in men (HRR = 1.04, 95% CI (0.53-2.05), P = 0.915). This association remained significant in women when controlled for fasting or 2-h plasma insulin concentrations, other estimates of insulin resistance or alcohol consumption. The protective effect of HDL cholesterol was similar among women with normal (2-h glucose < 7.8 mmol/1) or impaired (7.8 mmol/l < or = 2-h glucose < 11.1 mmol/l) glucose tolerance at baseline. These results indicate that lipoprotein disorders are an early accompaniment of the abnormalities that lead to NIDDM.
AuthorsA Fagot-Campagna, K M Narayan, R L Hanson, G Imperatore, B V Howard, R G Nelson, D J Pettitt, W C Knowler
JournalAtherosclerosis (Atherosclerosis) Vol. 128 Issue 1 Pg. 113-9 (Jan 03 1997) ISSN: 0021-9150 [Print] Ireland
PMID9051204 (Publication Type: Journal Article)
Chemical References
  • Blood Glucose
  • Cholesterol, HDL
  • Cholesterol, VLDL
  • Insulin
  • Lipoproteins
  • Lipoproteins, LDL
  • Lipoproteins, VLDL
  • Triglycerides
  • low density lipoprotein triglyceride
  • very low density lipoprotein triglyceride
Topics
  • Adult
  • Arizona
  • Blood Glucose (analysis)
  • Blood Pressure
  • Body Mass Index
  • Cholesterol, HDL (blood)
  • Cholesterol, VLDL (blood)
  • Diabetes Mellitus, Type 2 (blood, ethnology)
  • Female
  • Humans
  • Indians, North American
  • Insulin (blood)
  • Insulin Resistance
  • Lipoproteins (blood)
  • Lipoproteins, LDL (blood)
  • Lipoproteins, VLDL (blood)
  • Male
  • Proportional Hazards Models
  • Risk Factors
  • Triglycerides (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: